Calliditas Therapeutics AB Administrative Expense
Calliditas Therapeutics AB reported Administrative Expense of SEK 166.83 million for the 3-month period ending 2024-06-30, per its 6-K filed 2024-08-13.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdministrativeExpense · last filed 2024-08-13
- Calliditas Therapeutics AB administrative expense for the quarter ending 2024-06-30 was 166.83M SEK, a 116.24% increase year-over-year.
- Calliditas Therapeutics AB administrative expense for the quarter ending 2023-06-30 was 77.15M SEK, a 30.97% increase year-over-year.
- Calliditas Therapeutics AB administrative expense for the quarter ending 2022-06-30 was 58.91M SEK, a 126.53% increase year-over-year.
- Calliditas Therapeutics AB administrative expense for the quarter ending 2022-03-31 was 48.53M SEK, a 23.32% increase year-over-year.
| Period end | Administrative Expense 3 month | Administrative Expense 6 month | Administrative Expense 12 month |
|---|---|---|---|
| 2024-06-30 | 166.83M SEK 6-K · filed 2024-08-13 | 268.85M SEK 6-K · filed 2024-08-13 | |
| 2023-12-31 | 332.99M SEK 6-K · filed 2024-08-13 | ||
| 2023-06-30 | 77.15M SEK 6-K · filed 2024-08-13 | 149.70M SEK 6-K · filed 2024-08-13 | |
| 2022-12-31 | 259.47M SEK 20-F · filed 2024-04-24 | ||
| 2022-06-30 | 58.91M SEK 6-K · filed 2023-08-17 | 107.44M SEK 6-K · filed 2023-08-17 | |
| 2022-03-31 | 48.53M SEK 6-K · filed 2022-05-20 | ||
| 2021-12-31 | 210.63M SEK 20-F · filed 2024-04-24 | ||
| 2021-06-30 | 26.00M SEK 6-K · filed 2022-08-19 | 65.36M SEK 6-K · filed 2022-08-19 | |
| 2021-03-31 | 39.35M SEK 6-K · filed 2022-05-20 | ||
| 2020-12-31 | 102.76M SEK 20-F · filed 2023-04-26 |